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The stomach secretes a wide range of peptides with essential metabolic functions, and thereby plays an important role in the
regulation of energy homeostasis. Disulﬁde isomerase glucose-regulated protein 58 (GRp58) is a molecular chaperone member
of the endoplasmic reticulum (ER) stress signaling pathway, which is a marker for human gastric cancer. Since GRp58 seems
to be regulated by a phosphorylation/dephosphorylation pattern shift, we used the 2DE gel methodology and peptide mass
ﬁngerprinting-protein identiﬁcation by means of MALDI-TOF mass spectrometry. We show that gastric mucosa GRp58 is
dephosphorylated by fasting, and this eﬀect is blunted when fasted rats are treated with leptin. Furthermore, we assessed the
gene expression of GRp58 under diﬀerent physiological settings known to be associated with energy homeostasis (fasting, leptin
treatment and leptin deﬁciency). We found that intraperitoneal administration of leptin increases whereas leptin deﬁciency
decreases GRp58 mRNA levels. However, GRp58 expression remains unchanged after fasting, indicating that leptin actions on
GRp58 are no direct sensitivity to fasting. Dissection of the molecular pathways mediating the interactions between ER stress-
related factors and nutrient availability, as well as their target genes, may open a new avenue for the study of obesity and other
metabolic disorders.
1.Introduction
The stomach is a central metabolic crossroad wherein nu-
merous signals converge and depart to control nutrient in-
take, appetite, and general metabolic homeostasis [1]. Thus,
data gleaned over the last few years have shown that the
stomach plays a key role in the regulation of food intake
through the secretion of peptides such as ghrelin [2]. In ad-
dition, gastric emptying through the regulation of gastric
distension also inﬂuence the rate of intestinal exposure of
nutrients thereby inﬂuencing the secretion of a vast array of
gastrointestinal hormones which in turn also control food
intake and/or energy expenditure. Therefore, the stomach
has emerged as a key organ in the regulation of body
weight homeostasis, and gastric surgery is at the front line
of treatment of patients with morbid obesity. However, there
is a general lack of knowledge on the adaptation process that
takepartinthestomachinrelationtoenergybalance.Wefelt2 International Journal of Peptides
the critical question pending was to identify the subcellular
events that take place in this tissue and its relationship to
alterations in energy balance.
Disulﬁde isomerase glucose-regulated protein 58 (also
known as, GRp58, ERp57, ER-60, ERp60, ERp61) is a molec-
ular chaperone member of the ER-stress signaling pathway.
Speciﬁcally,GRp58isa58kDathiol-disulﬁdeoxidoreductase
protein, physiologically involved in the folding catalysts
modiﬁcation of disulﬁde bonds in glycoprotein [3, 4], and
has been previously identiﬁed in the stomach as a marker
for human gastric cancer [5]. Moreover, it is also highly
expressed in liver, placenta, and lung, and weakly expressed
in other tissues [4]. In vitro and in vivo studies have shown
that GRp58 protein acts on glycosylated substrates through
the ER resident lectins-calnexin and the calreticulin system
to catalyze the isomerization or exchange of disulﬁde bonds
[6, 7]. GRp58 substrates share common properties: they are
glycoprotein, heavily disulﬁde bonded, and likely to form
nonnative disulﬁde bonds [6, 7]. Most of these substrates
contain abundant domains of cysteine residues, which
usually promote formation of the disulﬁde bonds during
glycoprotein folding [6–8]. In line with the interrelation
among metabolism, ER-stress and chaperone function, it has
been shown that GRp58 expression is induced by diﬀerent
stress conditions, such as glucose deprivation or hypoxia
[9, 10]. Furthermore, hepatic GRp58 was phosphorylated
after 12-h/24-h fasting and after leptin treatment [11], and
interacts with the JAK-STAT signaling pathway implicated in
the intracellular signal transduction of leptin [12].
Although GRp58 is a marker for human gastric cancer
[5], few studies have addressed the regulation and potential
role of ER-stress, and in particular that of GRp58, in gastric
function. We aimed to investigate the involvement of GRp58
in energy homeostasis. Our results demonstrate that GRp58
is expressed in rat gastric and reveal that gastric GRp58
mRNAexpressionanddephosphorylationareincreasedafter
leptin treatment. Therefore, our results suggest that gastric
GRp58 might play an important role in the regulation of
energy homeostasis.
2. Methods and Procedures
2.1. Animals. Adult male Sprague Dawley rats (250–300g,
8–10 weeks old) were bred in the animalario General USC;
University of Santiago de Compostela, Spain, and male
leptin-deﬁcient mice (8 weeks old) were purchased from
Charles River, Barcelona, Spain. Animals were housed in
open cages under conditions of controlled illumination (12-
hour light/dark schedule), humidity, and temperature. The
animals were sacriﬁced by decapitation in a room separate
from other experimental animals in the afternoon (16:00-
17:00h). The gastric mucosa was then collected and frozen
at −80◦C until analysis. All experiments were conducted in
accordance with the European Union Laws on protection
regarding laboratory animals after previous approval by the
Ethics Committee of the University of Santiago de Com-
postela, Spain (Permit number: PGIDIT06PXIB208063PR).
2.1.1. Experimental Setting 1: Eﬀects of Fasting. Animal
groups (n = 8 per group) were deprived of food for 48h
while the control group was fed ad libitum [13]. All animals
had free access to tap water. Gastric mucosa was rapidly dis-
sectedandstoredat −80◦Cuntil proteomic andmRNA anal-
yses were performed.
2.1.2. Experimental Setting 2: Eﬀects of Leptin Treatment and
LeptinDeﬁciency. Wenextinvestigatedwhetherleptinaﬀects
gastric mucosa GRp58 mRNA expression and modiﬁcations
in the protein phosphorylation pattern shift. Rats and mice
were assigned to one of the following groups (n = 8p e r
group): (a) i.p. vehicle fed ad libitum; (b) i.p. leptin fed
ad libitum; (c) i.p. vehicle after 48h fasting and (d) i.p.
leptin after 48h fasting. On the other hand, leptin-deﬁcient
animals were distributed in three groups: (a) i.p. vehicle fed
ad libitum, (b) i.p. vehicle after 48h-fasting and (c) i.p. leptin
after 48h fasting. Animals were treated with recombinant
leptin (L-4146, Sigma-Aldrich) at a dose of 0.8μg/kg of body
weight every 12h for 3 days (intraperitoneal injection) as
described elsewhere [13].
For the proteomic setting, we treated rats with leptin at
short term: 6h and 24h before the sacriﬁce with a single
intraperitoneal injection (0,8μg/kg of body weight in a
volume of 0.25mL). We again had the same 4 groups (n = 4
per group). The reason we carried out this short-term ex-
periment for proteomic approaches is that the pattern shift
of phosphorylation/dephosphorylation is commonly faster
than changes at transcriptional level.
2.2.WesternBlotAnalysis. Westernblotanalysisfrom1Dand
2D gels were performed as described elsewhere [14]. Brieﬂy,
gastric mucosa proteins were resolved by polyacrylamide gel
electrophoresis according to the method described below
and transferred to nitrocellulose membrane (Hybond C-
Super, Amersham Pharmacia Biotech). Membranes were
incubated with primary antibodies against Erp57 (H-220;
sc-28823. Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and alpha-tubulin (Sigma; Poole, UK). The membranes after
incubationwithrespectivesecondaryantibodieswereprobed
with HRP-conjugated secondary antibodies and the signal
was developed with chemiluminescence reagents (Tropix,
Bedford; MA, USA) and exposed to X-ray ﬁlm. All the
experiments were repeated four times and a representative
result is shown.
2.3. Two-Dimensional Electrophoresis. 2DE analyses were
performedusingfoursamplespergroup.Gastricmucosawas
lysed at 4◦C using a tissue homogenizator (Omni Tis-
sueMaster-125Homogenizers).Lysateswerepreparedinlysis
buﬀer (7M urea, 2M thiourea, 4% CHAPS, 5mM mag-
nesium acetate, 20mMTris HCl pH 8.5, 0.2% ampholytes
w/v, and bromophenol trace). Samples were centrifuged at
15000g under 4◦C during 15min to remove the debris as
described previously [15].
First dimension isoelectric focusing was performed with
the horizontal Multiphor IPGphor III system (GE Health-
care, formerly Amersham Biosciences); using 11cm IPGInternational Journal of Peptides 3
strips (pH 4–7, GE Healthcare). The sample (50μg) was
dissolved by soaking in 200μLo fr e h y d r a t i o nb u ﬀer (7M
Urea, 2M thiourea, 4% CHAPS and bromophenol trace)
during 8 hours. Then, it was loaded onto an 11cm-lin-
ear range with pH 4–7 immobilized gradient strip (4 gels
per experimental group and each one originated from dif-
ferent animals) and isoelectric focusing was performed as
recommended by the manufacturer, ramping the voltage
subsequently applied to reach 6000Vht. The strips contain-
ing focused proteins were thawed, equilibrated, and reduced
in equilibration buﬀe r( 6 Mu r e a ,5 0 m MMT r i s - C lp H
8.8, 2% SDS, 30% glycerol, and 2% (w/v) DTT) during
15min, then alkylated in equilibration buﬀer (6M urea,
50mM Tris-Cl pH 8.8, 30% glycerol, 2% SDS, 2.5% (w/v)
iodoacetamide.EquilibratedstripsweretransferredtoaSDS-
PAGEgel(10%),securedinplacebymoltenagaroseandsub-
jected to electrophoresis (Mini-Protean Tetra Cell; Bio-Rad
Laboratories). Afterwards, electrophoresis gels were stained
using PlusOne Silver Staining Kit, Protein (GE Healthcare),
as recommended by the manufacturer protocols.
2.4. MALDI-TOF/TOF Mass Spectrometry and Protein Iden-
tiﬁcation. Spots were excised automatically in a ProPic
station(GenomicSolutions,UK)anddigestedwithmodiﬁed
porcine trypsin (sequencing grade; Promega), by using a
ProGest digestion station (Genomic Solutions, U.K.). The
gel specimens were destained twice over 30min at 37◦C
with 200mM ammonium bicarbonate/40% acetonitrile. Gel
pieces were then subjected to three consecutive dehydrata-
tion/rehydratation cycles with pure acetonitrile and 25mM
ammonium bicarbonate in 50% acetonitrile, respectively,
and ﬁnally dehydrated for 5min with pure acetonitrile and
dried out over 4h at room temperature. Then, 20μL trypsin,
at a concentration of 12.5ng/μL in 25mM ammonium bi-
carbonate was added to the dry gel pieces and the digestion
proceded at 37◦Cf o r1 2h .P e p t i d e sw e r ee x t r a c t e df r o mg e l
plugs by adding 1μL of 10% (v/v) triﬂuoracetic acid (TFA)
and incubating for 15min. Then, they were desalted and
concentrated by using μC-18 ZipTip columns (Millipore)
in a ProMS station (Genomic Solutions, U.K.) and directly
loaded onto the MALDI plate using α-cyano hydroxycin-
namic acid as the matrix.
Mass analysis of peptides of each sample were per-
formed with a MALDI-TOF/TOF (4700 Proteomics Ana-
lyzer, Applied Biosystems, USA) in automatic mode with the
following setting: for the MS data, m/z range 800 to 4000
with an accelerating voltage of 20kV and delayed extraction,
peak density of maximum 50 peaks per 200Da, minimal S/N
ratio of 10 and maximum peak at 65. Spectra were internally
calibrated with peptides from trypsin autolysis (M + H+ =
842.509, M + H+ = 2211.104).
For the MS/MS data, mass range was set between 60Da
and 10Da below each precursor mass, with a minimum S/N
ratio of 5, a maximum number of peak set at 65 and peak
density of maximum 50 peaks per 200Da. Proteins were
assigned identiﬁcation by peptide mass ﬁngerprinting and
conﬁrmed by MS/MS analysis. Mascot 2.0 search engine
(Matrix Science, U.K.) was used for protein identiﬁcation
running on GPS software (Applied Biosystems) over the
National Center for Biotechnology Information (NCBI) pro-
tein database (updated monthly).
Search setting allowed one missed cleavage with the se-
lected trypsin enzyme, an MS/MS fragment tolerance of
0.2Da and a precursor mass tolerance of 100ppm. Proteins
with a statistically signiﬁcant (P<0.05) were positively as-
signed identiﬁcation after considering Mr and pI values.
2.5. RNA Isolation and GRp58 mRNA Expression Analysis
by RT-PCR. Total RNA from gastric mucosa was extracted
using Trizol (Invitrogen, Inc.) according to the manufac-
turer’s instructions. RNA was reverse transcribed and the
resulting cDNA was synthesized from 2ug total RNA by
random priming RT. The resulting cDNA was subjected
to PCR ampliﬁcation as described at [13, 16] using sense
and antisense primers speciﬁc for the rat GRp58 and the
housekeeping gene hypoxanthine guanine phosphoribosyl-
transferase (HPRT) mRNAs (Table 1).
2.6.Real-TimeSemiquantitativeRT-PCR. Forreal-timesem-
iquantitative analysis we used the Applied Biosystems 7500
Real-Time PCR System (Applied Biosystems, CA, USA), as
previously described [13–15]. Rat GRp58 and 18S ribosomal
rRNArelativegeneexpressionquantiﬁcationwasmadeusing
speciﬁc primers and TaqMan ﬂuorescent probes for these
target genes, and the sequences are described in Table 1.
2.7. Statistical Analysis. The results are shown as the means
± SEM (standard error of the mean) and analyzed by using
GraphPad Instat 3.05 (GraphPad Software, Inc.) software.
Statistical signiﬁcance was determined by Student’s t-test
when two groups were compared. In the experiments
constituted by three groups the data were analyzed by one-
wayANOVAfollowedbyaposthocmultiplecomparisontest
(Bonferroni test). P<0.05 was considered signiﬁcant.
3. Results
3.1. Rat Gastric GRp58 mRNA Expression. Expression of the
mRNA encoding GRp58 gene (Figure 1) was evaluated by
RT-PCR and compared to housekeeping gene HPRT. This
analysis demonstrates the expression of the message of
the gene in male rat liver and gastric mucosa whereas its
expression was not found in tissues such as pancreas and
brain (Figure 1).
3.2. Rat Gastric GRp58 Protein Levels. After discovering that
GRp58 is expressed in the gastric mucosa by means of
RT-PCR, we employed Western blot analysis to determine
whether the message is translated into protein. Using a
speciﬁc primary antibody for GRp58, we detected a major
band in protein extracts of rat gastric, and observed that
protein levels of GRp58 were decreased after 24h and 48h
of fasting (Figure 2). Moreover, in the gastric mucosa of
rats fasted during 48h, we found that the band had a lower
molecular weight, likely suggesting a dephosphorylation
(Figure 2).4 International Journal of Peptides
Table 1: PCR primers and probe sequence for rat GRp58 and 18S ribosomal rRNA.
Primer/probe Sequence Genebank accession number
GRP58FW 5 -GGACCAGCTTCAGTTCCTCTCA-3 
NM 017319.1 GRP58RV 5 -TGCTGGCTGCTTTTAGGAACTC-3 
GRP58Pb FAM 5 -ATGCCTCGGTGGTGGGCTTTTTCA- 3 TAMRA
18SFW 5 -CGGCTACCACATCCAAGGAA-3 
M11188.1 18SRV 5 -GCTGGAATTACCGCGGCT-3 
18SPb FAM 5 -GACGGCAAGTCTGGTGCCAGCA-3 TAMRA
HPRT FW 5 -CAGTCCCAGCGTCGTGATTA-3 
NM 012583
HPRT RV 5 -AGCAAGTCTTTCAGTCCTGTC-3 
HPRT GRp58
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Figure 1: Expression of GRp58 gene in rat gastric. Representative
RT-PCR assay of the expression levels of GRp58 mRNA in liver
and gastric mucosa whereas pancreas and brain failed to show any
ampliﬁcation. HPRT was used as a housekeeping gene.
3.3. Proteomic Identiﬁcation and Molecular Analysis. To test
the hypothesis that GRp58 was dephosphorylated during
fasting, we performed proteomic analysis. Representative 2-
D Eg e li m a g e so fr a tg a s t r i ct i s s u ew i t hd i ﬀerential expressed
protein in fed state (Figure 3(a)) compared to fasted state
(Figure 3(b)). Diﬀerentially expressed protein spots (marked
with letters) were picked, digested with trypsin, and analyzed
by peptide mass ﬁngerprinting as previously described
(Tables 2 and 3)[ 17, 18]. The peptide mass ﬁngerprints
were acquired by mass spectrometry using a matrix-assisted
laser desorption/ionization time-of-ﬂight (MALDI-TOF).
All analyzed spots correspond to multiple phosphorylated
forms of GRp58 protein, which were identiﬁed by the
comparison of peptide mass ﬁngerprint data generated
by MALDI-TOF mass spectrometry against theoretically
digested Homo sapiens, Swiss-Prot and TrEMBL database,
andbytheuseofMascotsoftware.Amongtheidentiﬁedpro-
tein spots, a 4-protein series with identical molecular weight
of approximately 58kDa and diﬀerent isoelectric points
were identiﬁed as GRp58. These diﬀerences reﬂect diﬀerent
degrees of phosphorylation as previously described [19–21].
The identiﬁed phosphorylated forms of GRp58 protein in
rat gastric along with referred data are listed in Table 3.
These phosphorylation proﬁle shifts were identiﬁed through a
2-DE Western blot analysis using an anti-GRp58 antibody,
Table 2: Cutoﬀ score value for protein: 71 (score is −10 ∗ Log(P),
where P is the probability that the observed match is a random
event. Protein scores greater than 71 are signiﬁcant (P<0.05)).
The software used for peak-picking was 4000 Series Explorer (TM)
RAC Software, version 3.5.3 (Applied Biosystems/MDS SCIEX,
Concord, Ontario, Canada). Parameters and thresholds used for
peak-picking: (a) intensity or S/N threshold: S/N = 10, local noise
window width (m/z) = 250, min peak width at full width half
max (bins) = 2.9; (b) means of calibrating each spectrum: internal
calibrationwithpeptidesfromtrypsinautolysis(M+H+ =842.509,
M+H + = 2211.104); (c) resolution: 12000 for the mass 842.51
and 18000 for the mass 2211. Search parameters: (a) MASCOT
(Matrix Science, London, UK) software, VERSION 2.0; (b) enzyme
speciﬁcity: trypsin; (c) missed cleavages permitted: 1; (d) ﬁxed
modiﬁcation (s): carbamidomethyl (C); (e) variable modiﬁcations:
oxidation (M), Phospho (ST), Phospho (Y); (f) mass tolerance
for precursor ions: ±100ppm; (g) mass tolerance for fragment
ions: ±0.2Da; (h) name of database searched and release version:
NCBInr 20080628 (6655203 sequences); (i) species restriction:
Mammalia (mammals) (689751 sequences); (j) acceptance criteria:
cut-oﬀ score value for protein: 71 (score is -10∗Log(P), where P is
the probability that the observed match is a random event. Protein
scores greater than 71 are signiﬁcant (P<0.05)).
Spot No protein
score
protein
score 1%
Coverage
%
Number of
peptides
identiﬁed
P1  170 100 60 13
P2  149 100 50 12
P1 282 100 90 24
P2 439 100 95 24
P3 288 100 64 15
P4 237 100 55 12
recognizing four immunoreactive protein spots (Figures 4(a)
and 4(b)) that showed a basic shifted signal in the proﬁle of
GRp58.
3.4.FastingInducesGRp58DephosphorylationWhereasLeptin
Blunts Fasting-Induced Dephosphorylation of Gastric Mucosa
GRp58. Additionally, using 2DE, we found that 48h of
fasting dephosphorylated gastric mucosa GRp58 in com-
parison with rats fed ad libitum (Figure 5). When 48h
fasted-rats were treated with leptin for 6 hours or 24h, weInternational Journal of Peptides 5
Table 3: Identiﬁcation of GRp58 protein in the gastric mucosa of the rat. Rat gastric proteins were separated by 2-DE and identiﬁed by
means of MALDI-TOF. The protein identiﬁed represents the spots shown in Figures 1(a) and 1(b): protein disulﬁde-isomerase A3 precursor
(Disulﬁde isomerase ER-60; ERp60; 58kDa microsomal protein; p58; ERp57; HIP-70; Q-2; 35 petides), the spots labelled as P1  and P2  are
the same spots as P1 and P2 but in diﬀerent gels.
Protein MW: 57043.9 Protein PI: 5.88 Accession No: gi|1352384|
Observed Mr (expt) Mr (calc) ± da ± ppm Start-end Sequence Spot number
823.4785 823.4559 0.0226 27 190–196 IVAYTEK p1 ,p1
866.4574 866.4617 −0.0043 5 387–393 YKELGEK p1 ,p1
877.4915 877.489275 0.0025 3 268–275 LNFAVASR p1 ,p1
995.5628 995.5632 −0.0004 0 102–111 QAGPASVPLR p1 ,p1
997.5101 997.459 −0.0511 −51 153–161 DASVVGFFR p2
1084.5674 1084.5688 0.0014 1 95–104 YGVSGYPTLK p2 ,p1,p2,P3
1123.6582 1123.6589 0.0007 1 101–111 KQAGPASVPLR p1 ,p1
1125.547 1125.5436 0.0034 3 243–251 NTKGSNYWR p1
1172.5404 1172.4702 −0.0702 −60 336–344 FVMQEEFSR p1,p2
1179.5865 1179.6239 0.0374 32 174–183 AASNLRDNYR p2 ,p1,p2
1188.5354 1188.5305 −0.0049 −4 344–336 FVMQEEFSR p2 ,p1,p2,P3
1191.6005 1191.6084 0.0079 7 63–73 LAPEYEAAATR p1 ,p2 ,p1,p2,P3,P4
1236.5127 1236.5029 −0.0098 −8 108–119 DGEEAGAYDGPR p2 ,p1,p2,P3
1244.6633 1244.6276 −0.0357 −29 184–194 FAHTNVESLVK p1,P3
1341.6837 1341.683 −0.0007 −1 449–460 GFPTIYFSPANK p2 ,p1,p2,P3,P4
1347.7043 1347.7015 0.0028 2 33–44 RLAPEYEAAATR p1
1373.6736 1373.5839 −0.0897 −65 352–362 FLQEYFDGNLK p2
1394.6587 1394.5729 −0.0858 −62 162–173 DLFSDGHSEFLK p1,p2
1396.6954 1396.6727 −0.0227 −16 367–379 SEPIPETNEGPVK p2 ,p1,p2,P3,P4
1397.5784 1397.7063 0.1279 92 83–94 VDCTANTNTCNK p1 ,p2 ,p2,P3,P4
1397.7059 1397.7063 0.0004 0 472–482 ELNDFISYLQR p1 ,p2 ,p1,P3,P4
1469.7787 1469.691 −0.0877 −60 449–461 GFPTIYFSPANKK p1,p2,P4
1472.6838 1472.6184 −0.0654 −44 336–347 FVMQEEFSRDGK p2
1488.6787 1488.6698 −0.0089 −6 336–347 FVMQEEFSRDGK P3
1529.7747 1529.775 0.0003 0 352–363 FLQEYFDGNLKR p1 ,p2 ,p1,p2,P3,P4
1593.8483 1593.8551 0.0068 4 483–496 EATNPPIIQEEKPK p2 ,p1,p2,P3,P4
1607.7476 1607.764 0.0164 10 259–271 DLLTAYYDVDYEK p1 ,p2 ,p2,P3,P4
1636.7523 1636.6552 −0.0971 −59 434–448 MDATANDVPSPYEVK p1,p2,P4
1652.7472 1652.6615 −0.0857 −52 434–448 MDATANDVPSPYEVK p2
1652.7662 1652.7704 0.0042 3 105–119 IFRDGEEAGAYDGPR p1 ,p2 ,p1,p2,P3,P4
1744.8864 1744.7698 −0.1166 −67 131–146 QAGPASVPLRTEDEFK p2
1746.9286 1746.8311 −0.0975 −56 289–304 TFLDAGHKLNFAVASR p1 
1800.9377 1800.9132 −0.0245 −14 364–379 YLKSEPIPETNEGPVK p1 ,p2 ,p1,p2,P3,P4
1950.9331 1950.7816 −0.1515 −78 259–274 DLLTAYYDVDYEKNTK p2
2463.1279 2462.9673 −0.1606 −65 83–104 VDCTANTNTCNKYGVSGYPTLK p2
observedthatthefasting-inducedGRp58dephosphorylation
was blunted (Figure 5). Therefore, our results indicate that
the dephosphorylation of gastric mucosa GRp58 induced
by fasting, a hypoleptinemic state, is likely mediated by
circulating leptin levels.
3.5. Gastric Mucosa GRp58 mRNA Levels Are Induced by
Leptin. We then measured the mRNA expression of gastric
mucosa GRp58 in the same experimental paradigm de-
scribed above, meaning, fed ad libitum, fasted, and fasted
leptin-treated rats. We failed to detect any signiﬁcant change
in the gene expression of GRp58 of fasted rats when com-
pared to feed ad libitum rats (Figure 6(a)). However, we
found that leptin treatment was able to trigger gastric mu-
cosa GRp58 mRNA levels in fasted rats in comparison
with vehicle-treated rats (Figure 6(a)). Similar results were
detected in fed ad libitum rats, which showed a clear
upregulation in GRp58 gene expression after the leptin
treatment (Figure 6(b)). According to pharmacological data,
the endogenous lack of leptin downregulated gastric mucosa6 International Journal of Peptides
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Figure 2: Representative Western blot analysis (a) and quantiﬁ-
cation (b) of rat gastric GRp58 protein levels in fasted rats. Fifty
micrograms of total proteins were loaded on a 10% SDS-PAGE
gel. To conﬁrm equal loading, the same blot was stripped oﬀ
and incubated with monoclonal beta-tubulin antibody. Values are
mean ±S E Mo f8r a t sp e rg r o u p .
GRp58 gene expression when compared to wild-type mice
(Figure 6(c)). Finally, when leptin-deﬁcient mice were fasted
for 48h we failed to detect changes in GRp58 mRNA levels,
but when those fasted mice were treated with exogenous
leptin, an increase in gastric mucosa GRp58 gene expression
was found (Figure 6(d)). Overall, our ﬁndings show that
leptin is an important mediator of GRp58 gene expression
in the gastric mucosa.
4. Discussion
The endoplasmic reticulum (ER) is a multifunctional or-
ganelle that plays a critical role in multiple cellular processes
including,amongothers,proteinandlipidbiosynthesis,ster-
oid production, calcium homeostasis, and carbohydrate me-
tabolism [6]. In addition, the ER contains a large number
of calcium-dependent molecular chaperones and folding
enzymes, which are physiologically responsible for several
cotranslational and posttranslational modiﬁcations [22, 23].
Alterations in energy metabolism including glucose/energy
deprivation, oxidative injury, hypoglycemia, hypoxia, and
high-fat diet impair ER homeostasis. More speciﬁcally,
nutritional excess induces ER stress in subcutaneous adipose
tissue of obese human subjects [24]. Additionally, ER stress
has been related to the development of atherosclerosis and
diabetes [24–27]. For instance, obese humans and rodents
develop ER stress in liver and adipose tissues, leading to
insulin resistance whereas weight-loss decreases ER stress
and improves insulin sensitivity, suggesting a correlation
between ER stress and the metabolic syndrome [27, 28].
By using proteomics analysis, we found evidence of a
GRp58 phosphorylation/dephosphorylation pattern shift in
the rat gastric under changes in nutritional status. More
speciﬁcally,usingthe2DEgelmethodologyandpeptidemass
ﬁngerprinting-protein identiﬁcation by means of MALDI-
TOFmassspectrometry,weshowthatgastricmucosaGRp58
is dephosphorylated by fasting, and this eﬀect is blunted
when fasted rats are treated with leptin. GRp58, a well-
known stress protein, has been previously identiﬁed in the
stomach as a marker for human gastric cancer [5]. Fur-
thermore, previous works have demonstrated the presence
of leptin and leptin receptor in the stomach, suggesting
that gastric mucosa cells may be targets for leptin [29, 30].
GRp58 and signal transducer and activator of transcription
3 (STAT3), an essential signaling molecule mediating the
biological actions of leptin [31], have been localized in both
the cytoplasm and nucleus [32, 33]. In this regard, some
studies have shown that GRp58 may be implicated in the
transcriptional control of STAT3 [12, 32]. Notwithstanding
the evidence mentioned above, there was a general lack of
knowledge regarding a potential role of gastric GRp58 in
metabolism. Concurring with a role of gastric GRp58 on
energy balance, we demonstrate that leptin induces, whereas
leptin-deﬁciency reduces, gastric mucosa GRp58 mRNA
expression, suggesting that leptin modulates both GRp58
phosphorylation and expression. Since these eﬀects seem to
be nutritional, it is plausible to hypothesize that other tissues
that are target of leptin action in nutritional context like the
intestine might be also involved in the regulation of GRp58.
For instance, leptin is expressed and secreted by inﬂamed
colonic epithelial cells [34], it may act as a growth factor
in colon tissue [35]. Moreover, leptin receptors have been
located in the rat colonic epithelium [36]. Thus, the role of
leptin on GRp58 throughout the entire gastrointestinal tract
deserves further investigation.
Our ﬁndings obtained in rat gastric diﬀer from data ob-
tained in the rat liver, where it was found that serine 150
of GRp58 was phosphorylated by both fasting and leptinInternational Journal of Peptides 7
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Figure 3: Representative 2-DE gel image of gastric mucosa proteins from fed ad libitum (a) and 48h fasted (b) rats. Gastric proteins were
extracted from mucosa and separated on an immobilized pH 4–7 nonlinear gradient strip followed by separation on a 12% polyacrylamide
gel. Silver stained gel and spots diﬀerentially expressed proteins in fed controls relative to fasted rats were picked, and analysis by mass
spectrometry allowed the detection and identiﬁcation of diﬀerent GRp58 phosphorylated forms. Values are mean±SEM of 8 rats per group.
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Figure 4: 2DE gel electrophoretic analysis and immunoblot image of gastric mucosa proteins from fed (a) and 48h fasted (b) rats. Image
shows the position of GRp58 phosphorylated forms and alpha-tubulin detected by incubation with anti-GRp58, and anti alpha-tublin,
respectively. The position of GRp58 phosphorylated forms and alpha-tubulin in the silver-stained and nitrocellulose 2D is indicated by
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Figure 5: 2-DE gel image of GRp58 phosphorylation pattern of rat gastric from fed, 48h fasted rats, and 48h fasted rats treated with leptin
and sacriﬁced after 6h and 24h of leptin administration. GRp58 protein acidic isoelectric points decreased in 2DE gels in fasted and leptin
treated rats compared to vehicle-treated control fed rats. Gastric mucosa proteins were extracted and separated on an immobilized pH 4–
7 non-linear gradient strip followed by separation on a 12% polyacrylamide gel. Red arrows show the diﬀerent phosphorilation pattern
observed in diﬀerent treatments.
[11]. Thereby, those results were indicating that nutritional-
induced changes in liver GRp58 phosphorylation were not
mediated by circulating leptin levels. Our current data
demonstrating that leptin blocks the fasting-induced de-
phosphorylation of gastric GRp58 suggest that changes in
the activity of this protein are modulated by nutritional
status. Importantly, leptin seems to be responsible for those
nutritional-induced changes in gastric GRp58 phosphoryla-
tion. Moreover, the diﬀerent results obtained in the pattern
of GRp58 phosphorylation in the liver [11] and the stomach
suggests that GRp58 is regulated by nutritional status in
a tissue-speciﬁc manner. Since we have detected multiple
phosphorylated forms of GRp58 protein in the gastric
mucosa(Figure2),wehypothesizethatthesephosphorylated
forms could contribute to the tissue-speciﬁc regulation of
GRp58 in response to fasting and leptin treatment.
It is important to point out several issues that deserve
further attention. First, the functional role of phosphory-
lation/dephosphorylation of GRp58 caused by physiologi-
cal and physiopathological conditions is largely unknown.
Second, the sites of phosphorylation/dephosphorylation of
Grp58 are diﬀerent in each tissue [11, 37], so it might be
possible that the GRp58 phosphorylated forms that we
detectedinthegastricmucosaalsohavediﬀerentphosphory-
lation sites. Third, the factors that induce these phosphoryla-
tion/dephosphorylation shifts in a tissue-speciﬁc manner are
mostly unknown. All these issues seem relevant to elucidate
thepreciseroleandmechanismsmediatingGRp58actionsin
the organism.
Inadditiontotheactionsofnutritionalstatusonthepat-
tern of gastric mucosa GRp58 phosphorylation, we have also
assessed the regulation of GRp58 gene expression. Our ﬁnd-
ings indicate that leptin increases GRp58 mRNA expression
whereas leptin deﬁciency decreases the levels of this protein.
Since leptin lowers blood glucose levels and leptin-deﬁcient
mice are hyperglycemic, our results are in agreement with
previous in vitro results indicating that GRp58 expression is
induced by glucose deprivation [38].
Although GRp58 mRNA expression remained un-
changedafterfasting,wefoundthatitsproteinlevelswerede-
creased after 24h and 48h of fasting. These results suggest
that fasting modulates GRp58 at post-transcriptional levels.
Therefore, it is likely that the actions of leptin on GRp58
are dependent of nutritional status. On the other hand, the
ingestion of speciﬁc components of the diet like fructose
increases the secretion of gastric leptin [39], and this might
also aﬀect GRp58 gastric levels.
Taken together, our ﬁndings obtained on the dephos-
phorylation and total mRNA expression of GRp58 indicate
that leptin regulates the phosphorylation and expression of
gastricGRp58inrats.Italsoseemsreasonabletohypothesize
that at least some of the actions of leptin at the gastric level
might be mediated by GRp58 [40].
In conclusion, our results demonstrate that GRp58 phos-
phorylation responds rapidly to changes in dietary energy
and leptin treatment, and thereby support that GRp58 can
play an important physiological role in the signaling path-
ways related to energy balance in the stomach. More pre-
cisely, our ﬁndings indicate that (a) fasting dephosphorylates
gastric mucosa GRp58, (b) leptin blunts fasting-induced
GRp58 dephosphorylation, and (c) leptin stimulates gastric
mucosamRNAexpression.Dissectionofthemolecularpath-
ways mediating the interactions between ER stress-related
factors and nutrient availability, as well as their target genes
may open a new avenue for the study of obesity and other
metabolic disorders.International Journal of Peptides 9
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Figure 6: Gastric mucosa GRp58 mRNA levels in fed, 48h fasted rats, and 48h fasted rats treated with leptin (a). Gastric mucosa GRp58
mRNAlevelsinfedversusleptin-treatedrats(b).GastricmucosaGRp58mRNAlevelsinwild-typemiceversusleptin-deﬁcientmice(ob/ob)
(c). Gastric mucosa GRp58 mRNA levels in ob/ob mice fed ad libitum, fasted for 48h, and fasted for 48h treated with leptin (d). n = 8p e r
group. Gastric mucosa GRp58/18S were measured using RT-real time PCR. Mean ± SEM are reported.
∗P < 0.05,
∗∗P < 0.01.
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